Environmental

IRMD’s low R&D intensity versus medtech peers suggests a relatively light direct environmental footprint, but the metric is not a primary differentiator in this industry.

Zero debt and negative net debt reduce balance-sheet pressure for resource-intensive restructuring, yet peers with similar capital-light profiles limit any environmental advantage.

The provided metrics do not evidence material emissions, waste, or energy-management leadership, leaving IRMD broadly in line with smaller device peers rather than structurally advantaged.

Absence of disclosed environmental controversy in the supplied data supports a neutral risk profile, but limited disclosure visibility constrains confidence versus better-reporting peers.

Social

IRMD’s stock-based compensation at 2.5% of revenue indicates moderate employee dilution pressure, but it remains below many growth-oriented medtech peers with heavier equity pay.

High gross margin can support investment in product quality and training, yet the supplied data do not show a clear social-performance edge versus peers.

The available metrics do not capture workforce safety, product access, or customer outcomes, so IRMD cannot be credited with a stronger social profile than peers.

Limited disclosure on human-capital and patient-impact metrics keeps the social assessment near peer-average, despite the company’s relatively restrained compensation burden.

Governance

IRMD’s zero debt structure reduces creditor influence and refinancing risk, which is governance-positive versus leveraged peers with tighter covenant oversight.

Negative net debt indicates liquidity strength, supporting board flexibility and lowering the likelihood of governance stress from balance-sheet constraints.

Stock-based compensation at 2.5% of revenue is manageable relative to many peers, suggesting less dilution risk and more disciplined capital allocation.

The absence of disclosed governance controversies in the supplied data supports a stronger profile, although limited filing detail prevents a top-tier score.

Overall Score

IRMD screens as a moderate-to-strong ESG name versus peers, with governance the clearest relative strength and limited disclosure preventing a higher composite score.

Score Driver: Governance Strength From A Debt-Free Balance Sheet And Manageable Equity Compensation Relative To Peers.